Guardant Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-433.19	-416.28	-436.37	-479.45	-654.59	-384.77
Depreciation & Amortization	38.94	39.74	42.39	42.88	35.96	22.27
Stock-Based Compensation	176.07	166.22	140.41	90.76	94.69	151.45
Other Adjustments	50.73	39.99	74.58	-33.01	152.91	42.5
Change in Receivables	-21.12	-28.18	-21.39	8.38	0.38	-44.35
Changes in Inventories	-6.59	-14.79	-9.14	-10.35	-20.93	-7.96
Changes in Accounts Payable	46.06	52.75	-2.82	5.19	60.33	34.8
Changes in Accrued Expenses	-	-	-	83.4	-	-
Changes in Unearned Revenue	13.8	19.46	18.66	1.73	9.87	2.78
Changes in Other Operating Activities	-46.51	-43.67	-46.18	-34.51	11.91	-25.73
Operating Cash Flow	-187.69	-184.76	-239.86	-324.98	-309.46	-209.02
Capital Expenditures	-49.43	-48.31	-35.09	-20.49	-77.46	-75.04
Purchases of Investments	-1,075	-827.23	-314.82	-635.5	-327.72	-940.23
Proceeds from Sale of Investments	954.93	307.32	88.6	1,496	555	952.11
Payments for Business Acquisitions	-	-58.99	-	-	-	-
Investing Cash Flow	-230.65	-627.2	-261.31	840.25	149.82	-63.16
Long-Term Debt Issued	-	402.5	-	-	-	-
Net Long-Term Debt Issued (Repaid)	-	402.5	-	-	-	-
Issuance of Common Stock	31.85	360.14	14.84	482.54	11.94	17.87
Repurchase of Common Stock	-35.69	-75.55	-15.68	-11.2	-7.88	-83.76
Net Common Stock Issued (Repurchased)	-3.84	284.6	-0.84	471.35	4.06	-65.89
Other Financing Activities	-13.43	-15.96	-0.15	6.03	-193.16	-0.93
Financing Cash Flow	716.41	671.13	-1	477.38	-189.09	-66.82
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.48	0.49	-1.77	-0.91	-1.6	-1.69
Net Cash Flow	618.92	-140.34	-503.93	991.74	-350.34	-340.69
Free Cash Flow	-237.12	-233.07	-274.94	-345.46	-386.92	-284.05
FCF Margin	-21.95%	-23.73%	-37.20%	-61.26%	-86.07%	-76.02%
Free Cash Flow Per Share	-1.86	-1.86	-2.24	-3.08	-3.79	-2.80
Levered Free Cash Flow	-436.92	-8.6	-468.54	-411.59	-634.9	-454.55
Unlevered Free Cash Flow	-450.07	-430.75	-477.07	-498.03	-525.64	-460.2

SEC Filings: 10-K · 10-Q